Related Experiment Videos
Interaction of insulin-like growth factors with a nonfusing mouse muscle cell line: binding, action, and receptor
Abstract:
Insulin and the insulin-like growth factors (IGFs) are chemically related polypeptides that interact with distinct receptors and elicit the same biological responses. We have sought a readily propagated cell line from a potential target tissue in which to probe the multiple and complex interrelationships among receptor and effector pathways for these polypeptides. We now report that the mouse muscle cell line BC3H-1 represents such a model system. BC3H-1 cells differentiate spontaneously at high density to form cells with muscle-specific properties, but do not fuse. Standaert et al. reported that differentiated BC3H-1 myocytes possess insulin receptors that mediate glucose and amino acid uptake and are down-regulated by prolonged incubation with insulin. The present report demonstrates that BC3H-1 myocytes also possess functional and regulated IGF receptors. Two subtypes of IGF receptors, types I and II, differing in structure and peptide specificity, were demonstrated by competitive binding and affinity cross-linking experiments. Low concentrations of IGFs stimulated glucose incorporation and alpha-aminoisobutyric acid uptake by BC3H-1 myocytes, suggesting that these effects were mediated primarily by IGF receptors rather than insulin receptors. Preincubation with IGFs (or high concentrations of insulin) selectively down-regulated type I IGF receptors without affecting type II IGF receptors. Since [125I]IGF-I binds to both type I and type II receptors in BC3H-1 cells, and since type I receptors have a higher affinity for IGF-I, the selective down-regulation of type I IGF receptors results in an apparent decrease in affinity for IGF-I. This difference in the regulation of type I and type II receptors in BC3H-1 myocytes is consistent with observations in other systems in which only one IGF receptor was present or examined. In their ability to be down-regulated by IGFs and insulin, type I IGF receptors are more similar to the structurally homologous insulin receptors than to the structurally dissimilar type II IGF receptors. These findings indicate that the BC3H-1 cell line provides an excellent model system in which to study the structure-function relationships of the receptor and effector pathways for insulin and the IGFs.
Insights
The BC3H-1 mouse muscle cell line effectively models insulin and insulin-like growth factor (IGF) interactions. This system reveals distinct regulation of IGF receptor subtypes, crucial for understanding cellular signaling pathways.
Area of Science:
- Cell Biology
- Endocrinology
- Molecular Biology
Background:
- Insulin and insulin-like growth factors (IGFs) are related polypeptides with overlapping biological effects.
- Understanding their complex receptor and effector pathways requires a suitable model system.
- The mouse muscle cell line BC3H-1 differentiates into myocytes with muscle-specific properties.
Purpose of the Study:
- To investigate the presence and regulation of IGF receptors in BC3H-1 myocytes.
- To compare the regulation of IGF receptors with insulin receptors in this cell line.
- To establish BC3H-1 as a model for studying insulin and IGF signaling.
Main Methods:
- Utilized competitive binding and affinity cross-linking experiments to identify IGF receptor subtypes.
- Assessed glucose and amino acid uptake in response to IGFs and insulin.
- Investigated the down-regulation of IGF receptors following preincubation with IGFs or insulin.
Main Results:
- BC3H-1 myocytes possess functional type I and type II IGF receptors.
- Low concentrations of IGFs stimulated uptake, primarily via IGF receptors.
- IGFs and high insulin concentrations selectively down-regulated type I IGF receptors, not type II.
Conclusions:
- The BC3H-1 cell line serves as an excellent model for studying insulin and IGF receptor-effector pathways.
- Differential regulation of IGF receptor subtypes (I and II) was observed.
- Type I IGF receptors show regulatory similarities to insulin receptors, unlike type II receptors.